|
NKIRAS2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62436730732907E-12 |
| Normal-vs-Stage2 |
9.84990000000296E-05 |
| Normal-vs-Stage3 |
2.21234142117055E-12 |
| Normal-vs-Stage4 |
2.04825045813095E-12 |
| Stage1-vs-Stage2 |
9.700400E-02 |
| Stage1-vs-Stage3 |
3.008800E-01 |
| Stage1-vs-Stage4 |
7.945800E-01 |
| Stage2-vs-Stage3 |
3.774800E-01 |
| Stage2-vs-Stage4 |
9.576000E-02 |
| Stage3-vs-Stage4 |
2.751000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
5.5279000044095E-08 |
| Normal-vs-Asian |
6.40929999999873E-05 |
| Caucasian-vs-AfricanAmerican |
8.295400E-01 |
| Caucasian-vs-Asian |
6.794000E-01 |
| AfricanAmerican-vs-Asian |
7.660000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62592161956354E-12 |
| Normal-vs-Female |
<1E-12 |
| Male-vs-Female |
7.559400E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.58339999999968E-05 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.63202784619898E-14 |
| Normal-vs-Age(81-100Yrs) |
1.724090E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.142000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.767180E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.990210E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.385900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.213360E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.860400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.21230000000605E-05 |
| Normal-vs-Grade 2 |
1.62436730732907E-12 |
| Normal-vs-Grade 3 |
9.43689570931383E-15 |
| Normal-vs-Grade 4 |
1.61910485019234E-11 |
| Grade 1-vs-Grade 2 |
3.356100E-02 |
| Grade 1-vs-Grade 3 |
2.100900E-03 |
| Grade 1-vs-Grade 4 |
1.600380E-02 |
| Grade 2-vs-Grade 3 |
8.411700E-02 |
| Grade 2-vs-Grade 4 |
7.172200E-01 |
| Grade 3-vs-Grade 4 |
3.524000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
<1E-12 |
| Normal-vs-ccB subtype |
1.19929954855991E-10 |
| ccA subtype-vs-ccB subtype |
8.765900E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.63113966777928E-12 |
| Normal-vs-N1 |
1.036550E-04 |
| N0-vs-N1 |
1.465560E-01 |
|
|
